Showing results (261-270 of 276) with videos related to
Sort By:
Pageof 28
Blood Advances|September 3, 2021
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotypeRuben A L de Groen, Ronald van Eijk, Stefan Böhringer, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 14, 2020
The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registryL J H Brada, M S Walma, R M van Dam, et al.Blood Advances|April 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemiaRomy E van Weelderen, Christine J Harrison, Kim Klein, et al.Haematologica|April 29, 2022
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangementSimon Bomken, Amir Enshaei, Edward C Schwalbe, et al.Blood|March 17, 2026
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) StudyLeon D Kaulen, Lakshmi Nayak, Philipp Karschnia, et al.BMC Cancer|August 7, 2023
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trialJ L van Dam, E M M Verkolf, E N Dekker, et al.Blood Advances|August 8, 2023
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphomaDiede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze, et al.Blood Cancer Journal|April 29, 2025
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironmentRuben A L de Groen, Fleur A de Groot, Stefan Böhringer, et al.JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.European Journal of Cancer (Oxford, England : 1990)|October 20, 2024
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapiesFleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, et al.Pageof 28